COMPLIS

Details for Australian Trade Mark No. 1018687 (hide)

Owner BioCryst Pharmaceuticals, Inc. a Delaware corporation

Convention US 5 March 2004 78/379687

Service Davies Collison Cave

Filing Date 2 September 2004

Classes

Class 5 Pharmaceuticals for the treatment of hepatitis, Acquired Immune Deficiency Syndrome (AIDS), SARS, and West Nile virus; pharmaceuticals for the treatment of inflammatory bowel diseases, inflammatory connective tissue diseases and inflammatory skin diseases; pharmaceuticals for the treatment of autoimmune, cancer and cardiovascular diseases and disorders; pharmaceuticals for the treatment of obesity; pharmaceuticals for the treatment of influenza; and anti-infective pharmaceuticals; pharmaceuticals for the treatment of viral and inflammatory diseases, infections and disorders

Event Publications

27 October 2005 Application Accepted

23 February 2006 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1018688-JEFFERSON WELLS

1018686-SWIRL, TAP, BUFF